|
SEC62 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.70996591622952E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46229695019429E-11 |
| Normal-vs-Stage2 |
8.24380000041813E-07 |
| Normal-vs-Stage3 |
2.28470000029901E-07 |
| Normal-vs-Stage4 |
1.563840E-01 |
| Stage1-vs-Stage2 |
9.554000E-01 |
| Stage1-vs-Stage3 |
7.732400E-01 |
| Stage1-vs-Stage4 |
5.814200E-01 |
| Stage2-vs-Stage3 |
8.446800E-01 |
| Stage2-vs-Stage4 |
6.124200E-01 |
| Stage3-vs-Stage4 |
6.658200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34459110512353E-12 |
| Normal-vs-AfricanAmerican |
5.39519999787075E-08 |
| Normal-vs-Asian |
1.76305999999293E-05 |
| Caucasian-vs-AfricanAmerican |
1.906550E-01 |
| Caucasian-vs-Asian |
5.871400E-01 |
| AfricanAmerican-vs-Asian |
3.022800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7178480860025E-12 |
| Normal-vs-Female |
2.368100E-04 |
| Male-vs-Female |
4.756400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.67660000003089E-06 |
| Normal-vs-Extreme_Weight |
1.66799907219684E-12 |
| Normal-vs-Obese |
4.28769997284917E-09 |
| Normal-vs-Extreme_Obese |
4.94110000026637E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.692990E-01 |
| Normal_Weight-vs-Obese |
8.735200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.247200E-01 |
| Extreme_Weight-vs-Obese |
3.074500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.987200E-01 |
| Obese-vs-Extreme_Obese |
3.735200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.26729999999576E-05 |
| Normal-vs-Age(41-60Yrs) |
7.13240000393967E-08 |
| Normal-vs-Age(61-80Yrs) |
1.12132525487141E-14 |
| Normal-vs-Age(81-100Yrs) |
3.44349999625848E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.500200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.054100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.827500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.379500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.046560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.920200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.18043419062542E-13 |
| Normal-VS-Type2 PRCC |
7.40740802029904E-12 |
| Normal-VS-KIRP CIMP |
5.187600E-01 |
| Normal-VS-Unclassified PRCC |
1.007910E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.530000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.746970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.937830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.671210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.039200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.217600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.09783318389145E-13 |
| Normal-vs-N1 |
4.44729999999893E-05 |
| Normal-vs-N2 |
8.742400E-01 |
| N0-vs-N1 |
1.224290E-02 |
| N0-vs-N2 |
4.817800E-01 |
| N1-vs-N2 |
6.903000E-01 |
|
|
